These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 449682

  • 1. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
    McDonald TJ, Dupre J, Caussignac Y, Radziuk J, Van Vliet S.
    Metabolism; 1979 Apr; 28(4):300-7. PubMed ID: 449682
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of glucagon secretion by gastric inhibitory polypeptide in patients with hepatic cirrhosis and hyperglucagonemia.
    Dupre J, Caussignac Y, McDonald TJ, Van Vliet S.
    J Clin Endocrinol Metab; 1991 Jan; 72(1):125-9. PubMed ID: 1986010
    [Abstract] [Full Text] [Related]

  • 3. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
    Ross SA, Dupre J.
    Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
    [Abstract] [Full Text] [Related]

  • 4. Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.
    Dudley FJ, Alford FP, Chisholm DJ, Findlay DM.
    Gut; 1979 Oct; 20(10):817-24. PubMed ID: 533693
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
    Shankar TP, Fredi JL, Himmelstein S, Solomon SS, Duckworth WC.
    Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
    [Abstract] [Full Text] [Related]

  • 10. Interrelationships among insulin, glucagon, and gastric inhibitory polypeptide in insulinoma.
    Nelson RL, Service FJ, Go VL.
    Mayo Clin Proc; 1980 Mar; 55(3):138-45. PubMed ID: 6243728
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The differential effect of intragastric and intravenous tryptophan on plasma glucose, insulin, glucagon, GLI and GIP in the fasted rat.
    Tsiolakis D, Marks V.
    Horm Metab Res; 1984 May; 16(5):226-9. PubMed ID: 6376308
    [Abstract] [Full Text] [Related]

  • 13. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
    Lanng S, Thorsteinsson B, Røder ME, Orskov C, Holst JJ, Nerup J, Koch C.
    Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery.
    Kabadi UM, Eisenstein AB, Tucci J, Pellicone J.
    Am J Gastroenterol; 1984 Feb; 79(2):143-9. PubMed ID: 6364796
    [Abstract] [Full Text] [Related]

  • 18. Effect of dialysate glucose load on plasma glucose and glucoregulatory hormones in CAPD patients.
    Armstrong VW, Creutzfeldt W, Ebert R, Fuchs C, Hilgers R, Scheler F.
    Nephron; 1985 Feb; 39(2):141-5. PubMed ID: 3883205
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.